Amyris, Inc. – NASDAQ:AMRS

Add to watchlist

$0.052

+0.00

+4%

Market closed

Open in 3 days

-95.83%

month

-91.46%

quarter

-98.59%

year

Market Cap	N/A
Enterprise value	1.28B

P/E	-0.66
EV/Sales	4.76
EV/EBITDA	-2.68
Price/Sales	1.36
Price/Book	-0.76
PEG ratio	N/A
EPS	-1.83

Revenue	268.22M
EBITDA	-521.74M
Income	-628.26M
Revenue Q/Q	-2.81%
Revenue Y/Y	20.45%

Profit margin	-195.86%
Oper. margin	-219.63%
Gross margin	4.14%
EBIT margin	-219.63%
EBITDA margin	-194.52%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Amyris, Inc. (NASDAQ:AMRS): Profit margin
Jun 2022	65.20M	-108.54M	-166.47%
Sep 2022	71.12M	-167.27M	-235.17%
Dec 2022	75.80M	-150.66M	-198.76%
Mar 2023	56.08M	-201.77M	-359.78%

Amyris, Inc. (NASDAQ:AMRS): Debt to assets
Jun 2022	789440000	1.03B	130.86%
Sep 2022	754060000	1.15B	153.68%
Dec 2022	824932000	1.29B	156.7%
Mar 2023	679679000	1.32B	195.35%

Amyris, Inc. (NASDAQ:AMRS): Cash Flow
Jun 2022	-147.04M	-41.93M	3.26M
Sep 2022	-133.53M	-30.08M	81.28M
Dec 2022	-92.87M	-4.39M	142.90M
Mar 2023	-90.00M	-4.81M	41.61M

Amyris alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Google Trends

Amyris

Amyris, Inc. (NASDAQ:AMRS): Google Trends - Amyris
4 Aug 2024	22
11 Aug 2024	16
18 Aug 2024	18
25 Aug 2024	19
1 Sep 2024	17
8 Sep 2024	19
15 Sep 2024	17
22 Sep 2024	13
29 Sep 2024	14
6 Oct 2024	13
13 Oct 2024	10
20 Oct 2024	11
27 Oct 2024	11
3 Nov 2024	14
10 Nov 2024	15
17 Nov 2024	14
24 Nov 2024	14
1 Dec 2024	14
8 Dec 2024	16
15 Dec 2024	22

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Amyris
Job Openings

Amyris, Inc. (NASDAQ:AMRS): Job openings
Aug 2023	5
Sep 2023	5
Oct 2023	13
Nov 2023	16
Dec 2023	18
Jan 2024	22
Feb 2024	21
Apr 2024	15
May 2024	13
Jun 2024	12
Jul 2024	8
Dec 2024	12
Jan 2025	9
Feb 2025	19
May 2025	18
Jul 2025	18
Aug 2025	19

Amyris
Employees

Amyris, Inc. (NASDAQ:AMRS): Employee count
Aug 2023	1,598
Sep 2023	1,598
Oct 2023	1,598
Nov 2023	1,598
Dec 2023	1,598
Jan 2024	1,598
Feb 2024	1,598
Mar 2024	1,598
Apr 2024	1,598
May 2024	1,598
Jun 2024	1,598
Jul 2024	1,598

Amyris
Hedge Funds Holdings Q2 2022

42.75% -7.49%

of AMRS is owned by hedge funds

201 -12

hedge funds hold AMRS stock

138.38M -8.63M

shares is hold by hedge funds

AMRS hedge funds holdings changes

Amyris, Inc. (NASDAQ:AMRS): Insider trades (number of shares)
Period	Buy	Sel
Jul 2022	0	55576
Aug 2022	17155	0
Sep 2022	0	3788592
Apr 2023	0	231368
Jun 2023	0	20999

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	2 Jun 2023	KIEFTENBELD HERMANUS officer: CHIEF FI..	Common Stock	17,499	$0.95	$16,624
Sale	2 Jun 2023	KIEFTENBELD HERMANUS officer: CHIEF FI..	Common Stock	3,500	$0.95	$3,325
Sale	5 Apr 2023	ALVAREZ EDUARDO officer: CHIEF OP..	Common Stock	231,368	$1.23	$284,351
Option	4 Apr 2023	ALVAREZ EDUARDO officer: CHIEF OP..	Common Stock	492,000	N/A	N/A
Option	4 Apr 2023	ALVAREZ EDUARDO officer: CHIEF OP..	Performance-based Restricted Stock Units	492,000	N/A	N/A
Sale	21 Sep 2022	KUNG FRANK director director	Common Stock	36,488	$3.5	$127,708
Sale	20 Sep 2022	KUNG FRANK director director	Common Stock	72,972	$3.6	$262,699
Sale	20 Sep 2022	KUNG FRANK director director	Common Stock	327,028	$3.6	$1,177,301
Sale	19 Sep 2022	KUNG FRANK director director	Common Stock	197,148	$3.8	$749,162
Sale	19 Sep 2022	KUNG FRANK director director	Common Stock	883,528	$3.8	$3,357,406

Status	Patent	Filling date	Issue date
Application	Application MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN Filling date: 31 Jul 2020 Issue date: 8 Sep 2022	31 Jul 2020	8 Sep 2022
Application	Application COMPOSITIONS AND METHODS FOR GENOMIC INTEGRATION OF NUCLEIC ACIDS INTO EXOGENOUS LANDING PADS Filling date: 9 Mar 2022 Issue date: 11 Aug 2022	9 Mar 2022	11 Aug 2022
Grant	Grant Utility: Methods for genomic integration Filling date: 11 Mar 2020 Issue date: 19 Jul 2022	11 Mar 2020	19 Jul 2022
Grant	Grant Utility: Methods for genomic integration in pichia and other host cells Filling date: 12 Sep 2018 Issue date: 19 Jul 2022	12 Sep 2018	19 Jul 2022
Application	Application OLEFINS AND METHODS FOR MAKING THE SAME Filling date: 3 Nov 2021 Issue date: 19 May 2022	3 Nov 2021	19 May 2022
Application	Application MICROBIAL PRODUCTION OF COMPOUNDS Filling date: 13 Mar 2020 Issue date: 28 Apr 2022	13 Mar 2020	28 Apr 2022
Grant	Grant Utility: Methods for recovering water-immiscible isoprenoid compounds from microbial biomass Filling date: 27 Jun 2019 Issue date: 26 Apr 2022	27 Jun 2019	26 Apr 2022
Application	Application ABC TRANSPORTERS FOR THE HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES Filling date: 23 Jan 2020 Issue date: 7 Apr 2022	23 Jan 2020	7 Apr 2022
Grant	Grant Utility: Compositions and methods for genomic integration of nucleic acids into exogenous landing pads Filling date: 18 May 2017 Issue date: 5 Apr 2022	18 May 2017	5 Apr 2022
Grant	Grant Utility: Methods for stabilizing production of acetyl-coenzyme A derived compounds Filling date: 2 Jan 2020 Issue date: 25 Jan 2022	2 Jan 2020	25 Jan 2022

Amyris
Earnings Call Transcripts

Quarter	Transcript
Q1 2023 9 May 2023	Q1 2023 Earnings Call Transcript
Q4 2022 16 Mar 2023	Q4 2022 Earnings Call Transcript
Q3 2022 8 Nov 2022	Q3 2022 Earnings Call Transcript
Q2 2022 9 Aug 2022	Q2 2022 Earnings Call Transcript

AMRS earnings call transcripts

Amyris
Executives

Insider	Age	Compensation
Mr. John G. Melo (1966) Pres, Chief Executive Officer & Director	59	$1,340,000
Mr. Eduardo Alvarez (1964) Chief Operating Officer	61	$959,760
Mr. Hermanus Kieftenbeld (1966) Chief Financial Officer & Chief Admin. Officer	59	$817,840
Ms. Nicole Kelsey (1967) Gen. Counsel & Sec.	58	$541,530

Amyris
Latest News

Tuesday, 17 September 2024
14:30	Squalene Market to Grow by USD 62.9 Million from 2024-2028, Driven by Rising Adoption of UVA/UVB Filters in Sunscreens, Report Powered by AI - Technavio	https://www.prnewswire.com
Friday, 11 August 2023
11:22	Retail investors flock to penny stocks WeWork, Amyris, Proterra	Reuters
10:34	AMRS Stock Surges 152% as Amyris Files for Bankruptcy	InvestorPlace
Thursday, 10 August 2023
11:50	Biotech Company Amyris Files for Bankruptcy	Investopedia
09:05	Why Is Amyris (AMRS) Stock Down 67% Today?	InvestorPlace
Monday, 7 August 2023
14:50	Amyris Warns Of Potential Bankruptcy - Sell	Seeking Alpha
Tuesday, 11 July 2023
10:19	Is It Time to Buy This Year's Worst-Performing Growth Stocks?	The Motley Fool
Monday, 3 July 2023
14:26	Amyris: CEO's Exit Has Negative Implications	Seeking Alpha
Thursday, 29 June 2023
13:20	10 Top Penny Stocks To Watch Right Now For Under $1	PennyStocks
Tuesday, 27 June 2023
04:23	Amyris: Company Separates From Long-Standing CEO Amid Ongoing Restructuring Efforts - Sell	Seeking Alpha
Wednesday, 7 June 2023
14:19	3 Hot Penny Stocks To Watch Before Next Week	PennyStocks
Tuesday, 6 June 2023
13:29	3 Penny Stocks Under $1 To Watch This Week; Time To Buy?	PennyStocks
Thursday, 1 June 2023
13:07	Hot Penny Stocks To Watch After UCAR Stock Explodes	PennyStocks
Friday, 19 May 2023
13:01	Amyris (AMRS) Q1 Earnings In Line, Revenues Beat Estimates	Zacks Investment Research
Monday, 1 May 2023
09:34	Top 5 Materials Stocks That May Explode In May - Amyris (NASDAQ:AMRS), MP Materials (NYSE:MP)	Benzinga
Friday, 28 April 2023
11:41	5 Top Penny Stocks To Buy According To Analysts, Targets Up To 165%	PennyStocks
Monday, 24 April 2023
14:37	3 Biotech Stocks to Sell Before They're 6 Feet Under	InvestorPlace
Wednesday, 19 April 2023
09:33	Amyris: Sub-Scale With High Fixed Costs And Limited Growth	Seeking Alpha
Monday, 17 April 2023
12:22	Amyris May be Oversold, but is it Worth Fighting the Shorts?	MarketBeat
Monday, 10 April 2023
07:39	Amyris (AMRS) and Givaudan Close Cosmetic Ingredients Deal	Zacks Investment Research
Friday, 17 March 2023
13:45	Amyris (AMRS) Q4 Earnings and Revenues Lag Estimates	Zacks Investment Research
Thursday, 16 March 2023
00:23	Amyris, Inc. (AMRS) Q4 2022 Earnings Call Transcript	Seeking Alpha
Wednesday, 15 March 2023
19:48	Amyris, Inc. (AMRS) Reports Q4 Loss, Misses Revenue Estimates	Zacks Investment Research
Tuesday, 14 March 2023
15:35	7 Penny Stocks To Watch Under $5 With Unusual Options Action	PennyStocks
Wednesday, 22 February 2023
09:55	Penny Stocks To Buy? 7 To Watch Now After Big News	PennyStocks
Friday, 17 February 2023
11:08	The Next Big Disruptors? 3 Biotech Stocks Making Headlines.	InvestorPlace
Monday, 13 February 2023
13:59	The 7 Best Stocks to Short This Week	InvestorPlace
Monday, 23 January 2023
11:32	4 Penny Stocks To Watch This Week With High Short Interest	PennyStocks
Thursday, 12 January 2023
10:50	Amyris: Darkest Before The Dawn	Seeking Alpha
Monday, 19 December 2022
13:00	3 Top Biotech Penny Stocks Under $3 To Watch Right Now	PennyStocks

Frequently Asked Questions (FAQ)

What's the price of Amyris stock today?

One share of Amyris stock can currently be purchased for approximately $0.05.
When is Amyris's next earnings date?

Unfortunately, Amyris's (AMRS) next earnings date is currently unknown.
Does Amyris pay dividends?

No, Amyris does not pay dividends.
What is Amyris's stock symbol?

Amyris, Inc. is traded on the NASDAQ under the ticker symbol "AMRS".
What is Amyris's primary industry?

Company operates in the Basic Materials sector and Chemicals - Specialty industry.
How do i buy shares of Amyris?

Shares of Amyris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Amyris's key executives?
Amyris's management team includes the following people:
- Mr. John G. Melo Pres, Chief Executive Officer & Director(age: 59, pay: $1,340,000)
- Mr. Eduardo Alvarez Chief Operating Officer(age: 61, pay: $959,760)
- Mr. Hermanus Kieftenbeld Chief Financial Officer & Chief Admin. Officer(age: 59, pay: $817,840)
- Ms. Nicole Kelsey Gen. Counsel & Sec.(age: 58, pay: $541,530)
How many employees does Amyris have?

As Jul 2024, Amyris employs 1,598 workers.
When Amyris went public?

Amyris, Inc. is publicly traded company for more then 14 years since IPO on 28 Sep 2010.
What is Amyris's official website?

The official website for Amyris is amyris.com.
Where are Amyris's headquarters?

Amyris is headquartered at 5885 Hollis Street, EmeryVille, CA.
How can i contact Amyris?

Amyris's mailing address is 5885 Hollis Street, EmeryVille, CA and company can be reached via phone at +51 04500761.

Amyris, Inc.

amyris.com

Exchange:

NASDAQ

Full time employees:

1,598

Industry:

Chemicals - Specialty

Sector:

Basic Materials

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

+51 04500761

5885 Hollis Street
EmeryVille, CA 94608

CIK: 0001365916
ISIN: US03236M2008
CUSIP: 03236M200